After registering, you will receive a confirmation email containing information about joining the meeting.
If the saying is “a picture says a thousand words”, then a recorded video must really speak volumes. But who needs a thousand when just two will do?
Click here to check out St. Paul’s Foundation Thank-You video to all of us who support the good work the group does there for scleroderma patients, the scleroderma clinic and the SABC research program.
CLICK HERE to find out what the BC CDC is saying about the 3rd dose for scleroderma patients.
What is Scleroderma?
Scleroderma (systemic sclerosis or SSc) is a largely misunderstood chronic disease affecting about approximately 22,000 Canadian and five to six times more women than men are affected by this disease.
Scleroderma is an autoimmune disease, a condition in which a person’s immune system turns against itself by producing antibodies that attack its own tissues (i.e. autoantibodies).
This disease is derived from the Greek words “skleros” (hard) and “derma” (skin) and is characterized by progressive skin hardening.
Nicknamed “the disease that mummifies” scleroderma is diagnosed in thousands of Canadians. It is characterized by an overproduction of collagen and damage to the blood vessels that causes excessive scarring within the various organs. This imbalance leads to a hardening of the skin (fibrosis) and an alteration of the affected organs. Moreover, in most cases, scleroderma limits the motor skills and dexterity of those affected and causes great physical and psychological suffering since it produces disfiguring appearance-related changes. Read more